VanEck Uranium+Nuclear Energy ETF Stock Forecast, Price & News

VanEck Uranium+Nuclear Energy ETF (NYSEARCA:NLR) Frequently Asked Questions

What stocks does MarketBeat like better than VanEck Uranium+Nuclear Energy ETF?

Wall Street analysts have given VanEck Uranium+Nuclear Energy ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but VanEck Uranium+Nuclear Energy ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has VanEck Uranium+Nuclear Energy ETF's stock price been impacted by Coronavirus (COVID-19)?

VanEck Uranium+Nuclear Energy ETF's stock was trading at $43.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NLR stock has increased by 22.9% and is now trading at $53.3423.
View which stocks have been most impacted by COVID-19.

Is VanEck Uranium+Nuclear Energy ETF a good dividend stock?

VanEck Uranium+Nuclear Energy ETF pays an annual dividend of $1.10 per share and currently has a dividend yield of 2.03%.
View VanEck Uranium+Nuclear Energy ETF's dividend history.

What other stocks do shareholders of VanEck Uranium+Nuclear Energy ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Uranium+Nuclear Energy ETF investors own include Incyte (INCY), Intercept Pharmaceuticals (ICPT), iShares Gold Trust (IAU), Genfit (GNFT), SPDR Gold Shares (GLD), Global Blood Therapeutics (GBT), DBV Technologies (DBVT), Loncar Cancer Immunotherapy ETF (CNCR), Clovis Oncology (CLVS) and BeiGene (BGNE).

What is VanEck Uranium+Nuclear Energy ETF's stock symbol?

VanEck Uranium+Nuclear Energy ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "NLR."

Who are VanEck Uranium+Nuclear Energy ETF's major shareholders?

VanEck Uranium+Nuclear Energy ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include LPL Financial LLC (4.24%), Catalyst Capital Advisors LLC (0.39%), Advisor Group Holdings Inc. (0.34%), Morgan Stanley (0.10%) and Morgan Stanley (0.10%).

Which institutional investors are selling VanEck Uranium+Nuclear Energy ETF stock?

NLR stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, and Advisor Group Holdings Inc..

Which institutional investors are buying VanEck Uranium+Nuclear Energy ETF stock?

NLR stock was acquired by a variety of institutional investors in the last quarter, including LPL Financial LLC, and Catalyst Capital Advisors LLC.

How do I buy shares of VanEck Uranium+Nuclear Energy ETF?

Shares of NLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Uranium+Nuclear Energy ETF's stock price today?

One share of NLR stock can currently be purchased for approximately $53.34.

How much money does VanEck Uranium+Nuclear Energy ETF make?

VanEck Uranium+Nuclear Energy ETF has a market capitalization of $27.58 million.